WHO ICTRP trial

Urine HPV testing in women over 65 years of age

ISRCTN39388293 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting

Key facts

Trial ID ISRCTN39388293
Public title Urine HPV testing in women over 65 years of age
Scientific title Urine HPV testing for cervical screening in women over 65: Alternative CErvical Screening (ACES) Over 65's
Primary sponsor University of Manchester
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Recruiting
Study type Observational
Phase Not Applicable
Countries United Kingdom;England
Conditions Identification of cervical cancer risk in women over 65 years of age using urine HPV testing Cancer Malignant neoplasm of cervix uteri
Interventions This study will establish the feasibility of combining cancer screening services in a community setting, the uptake of urine HPV testing in underserved communities, and whether the prevalence of HR-HPV in women aged 65-79 justifies…
Registration date May 16, 2022
Target size 3000
Secondary IDs Nil known;Nil known;IRAS 309115, CPMS 51689
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations